Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Episode 9 - Role of the Cardiologist in Treatment of T2D and CVD Risk Management

    Episode 9 - Role of the Cardiologist in Treatment of T2D and CVD Risk Management

    FromKnow Diabetes by Heart™ Professional Education Podcast Series

    Start listeningView podcast show

    Episode 9 - Role of the Cardiologist in Treatment of T2D and CVD Risk Management

    FromKnow Diabetes by Heart™ Professional Education Podcast Series

    ratings:
    Length:
    28 minutes
    Released:
    Aug 19, 2019
    Format:
    Podcast episode

    Description

    In a recent survey of people age 45 and older with type 2 diabetes, conducted online by The Harris Poll, only half recognize their cardiovascular risk or have discussed their risk of heart attacks or strokes with their health care providers. Listen to cardiologist, Dr. Tracy Wang and endocrinologist, Dr. Robert Eckel discuss how a cardiologist can play a pivotal role in helping his/her patients with type 2 diabetes better manage their cardiovascular disease risk.
    Released:
    Aug 19, 2019
    Format:
    Podcast episode

    Titles in the series (32)

    The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The American Heart Association’s and the American Diabetes Association's Know Diabetes by Heart Professional Education™ Podcast Series is brought to you by founding sponsors, Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance and Novo Nordisk, and national sponsors, Sanofi, AstraZeneca, and Bayer.